We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Himax Technologies
HIMX
$2.03B
| $11.2M | 0.01% |
+730,256
| New | +$11.3M |
2026 Q2
0 quarters
|
|
977
Simpson Manufacturing
SSD
$7.23B
| $11.2M | 0.01% |
53,334
+9,515
| +22% | +$1.78M |
2024 Q2
8 quarters
|
|
978
Watsco Inc
WSO
$12.2B
| $11.1M | 0.01% |
26,755
+12,425
| +87% | +$4.99M |
2026 Q1
1 quarter
|
|
979
Steris
STE
$21.7B
| $11.1M | 0.01% |
52,768
+42,088
| +394% | +$9.02M |
2025 Q4
2 quarters
|
|
980
Avient
AVNT
$3.58B
| $11.1M | 0.01% |
300,520
+188,574
| +168% | +$6.83M |
2022 Q4
14 quarters
|
|
981
Portillo's
PTLO
$338M
| $11.1M | 0.01% |
2,341,610
+645,050
| +38% | +$3.12M |
2026 Q1
1 quarter
|
|
982
CALL
Oracle
ORCL
$389B
| $11M | 0.01% |
75,400
-445,800
| -86% | -$80.8M |
2025 Q1
5 quarters
|
|
983
PennyMac Financial
PFSI
$3.13B
| $11M | 0.01% |
126,725
+69,222
| +120% | +$6.02M |
2026 Q1
1 quarter
|
|
984
Capital Group Global Growth Equity ETF
CGGO
$11.6B
| $11M | 0.01% |
+260,704
| New | +$10.1M |
2026 Q2
0 quarters
|
|
985
Globe Life
GL
$13B
| $11M | 0.01% |
61,638
+55,046
| +835% | +$8.62M |
2024 Q3
7 quarters
|
|
986
e.l.f. Beauty
ELF
$6.7B
| $11M | 0.01% |
+148,778
| New | +$9.04M |
2026 Q2
0 quarters
|
|
987
Brown & Brown
BRO
$23.2B
| $11M | 0.01% |
171,498
-74,851
| -30% | -$4.57M |
2025 Q4
2 quarters
|
|
988
RELX
RELX
$67.8B
| $10.9M | 0.01% |
343,547
+25,311
| +8% | +$857K |
2025 Q3
3 quarters
|
|
989
Franco-Nevada
FNV
$47B
| $10.9M | 0.01% |
52,068
+40,215
| +339% | +$9.37M |
2025 Q2
4 quarters
|
|
990
Tecnoglass Holdings
TGLS
$1.68B
| $10.8M | 0.01% |
231,507
-63,516
| -22% | -$2.75M |
2024 Q4
6 quarters
|
|
991
Celestica
CLS
$38.3B
| $10.8M | 0.01% |
29,673
+27,314
| +1,158% | +$10.2M |
2025 Q1
5 quarters
|
|
992
Dorian LPG
LPG
$2.29B
| $10.8M | 0.01% |
+310,201
| New | +$12.2M |
2026 Q2
0 quarters
|
|
993
MoonLake Immunotherapeutics
MLTX
$813M
| $10.7M | 0.01% |
550,351
+439,020
| +394% | +$7.96M |
2026 Q1
1 quarter
|
|
994
Miami International Holdings
MIAX
$3.07B
| $10.7M | 0.01% |
287,480
+164,861
| +134% | +$7.37M |
2026 Q1
1 quarter
|
|
995
Howard Hughes
HHH
$4.1B
| $10.7M | 0.01% |
149,314
+100,947
| +209% | +$6.57M |
2023 Q4
10 quarters
|
|
996
LG Display
LPL
$2.63B
| $10.7M | 0.01% |
2,743,945
+1,494,495
| +120% | +$6.86M |
2025 Q2
4 quarters
|
|
997
Immunome
IMNM
$1.94B
| $10.6M | 0.01% |
500,537
-980,251
| -66% | -$21M |
2024 Q1
9 quarters
|
|
998
Allogene Therapeutics
ALLO
$453M
| $10.6M | 0.01% |
5,095,408
+1,647,424
| +48% | +$3.62M |
2025 Q4
2 quarters
|
|
999
State Street
STT
$45.5B
| $10.6M | 0.01% |
+62,275
| New | +$9.6M |
2026 Q2
0 quarters
|
|
1000
CMS Energy
CMS
$21.5B
| $10.5M | 0.01% |
+137,065
| New | +$10.3M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.